-
BOC Sciences Recently Updates Its Metabolites and Impurities Collection
Dec 4, 2018, 01:02 AM by Michael CroftLONG ISLAND CITY, NY, UNITED STATES - Dec 4, 2018 - Starting from the year of 2013, BOC Sciences has been providing a wide variety of metabolites and impurities for scientists in the research communityFull story -
Creative Peptides Released Post-translational Modification for Science Community
Dec 4, 2018, 00:58 AM by Michael CroftLONG ISLAND CITY, NY, UNITED STATES - Dec 4, 2018 - Earlier this October, Creative Peptides, one of the worlds leading peptide manufacturers, has announced a series of peptide modification servicesFull story -
TARGET PharmaSolutions® Announces Partnership with Bristol Myers Squibb to Advance Inflammatory Bowel Disease (IBD) Research
Dec 3, 2018, 11:27 AM by Michael CroftCHAPEL HILL, NC, UNITED STATES - Dec 3, 2018 - TARGET PharmaSolutions, Inc., a company focused on real-world evidence, is pleased to announce that Bristol Myers Squibb has entered into a strategic partnership for TARGET-IBDFull story -
Despite CRISPR Baby Controversy, Harvard University Will Begin Gene-Editing Sperm
Nov 30, 2018, 11:22 AM by Michael CroftMIT Technology Review | Even as a furious debate broke out in China over gene-edited babies, some scientists in the US are also hoping to improve tomorrow's children.Full story -
MDI Biological Laboratory Scientist Receives Scientific Innovation Award
Nov 30, 2018, 11:17 AM by Michael CroftBAR HARBOR, ME, UNITED STATES - Nov 30, 2018 - Vicki P. Losick, Ph.D., has been named the inaugural recipient of an award from the William Procter Scientific Innovation FundFull story -
Greenphire Named to Deloitte's 2018 Technology Fast 500™ for Fifth Consecutive Year
Nov 30, 2018, 09:45 AM by Michael CroftKING OF PRUSSIA, PA, UNITED STATES - Nov 27, 2018 - Greenphire, the global leader in financial technology for clinical trials, announced today that it has been ranked as 391 on Deloitte's 2018 Technology Fast 500Full story -
CD Genomics Announces Highly Accurate and Sensitive MicroRNA Expression Profiling Microarray for Conducting a Genome-wide Analysis
Nov 30, 2018, 01:59 AM by Michael CroftSHIRLEY, NY - Nov 30, 2018 - CD Genomics, an expert in transcriptomics and next generation sequencing company, announces the launch of its microRNA expression profiling microarray services, which are based on some of the most powerful platforms in this field with unrivaled accuracy and sensitivityFull story -
Facing Backlash, Chinese Scientist Defends Gene-Editing Research On Babies
Nov 28, 2018, 12:30 PM by Michael CroftNPR.org | He Jiankui, who shocked the world by asserting he had genetically edited twin girls, faced growing criticism from other researchers as he spoke at a scientific conference in Hong Kong.Full story -
UberCloud, The Wellcome Sanger Institute, Panasas, And More: News From November 2018
Nov 28, 2018, 11:35 AM by Michael CroftFull storyBio-IT World | November featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including UberCloud, the Wellcome Sanger Institute, Panasas, and more.
-
Certara Launches Trial Simulator 2.3 to Improve Clinical Trial Success
Nov 28, 2018, 11:14 AM by Michael CroftPRINCETON, NJ - Nov 28, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced the launch of version 2Full story -
CanDIG to Power Canadian National Genomics Data Service, CHORD
Nov 27, 2018, 14:45 PM by Michael CroftTORONTO, ON, CANADA - Nov 27, 2018 - Data volumes everywhere are growing rapidly. In genomics — the study of the entirety of genetic information of individuals and populations— new sequencing technologies and techniques are turning this flood into a torrent, and all of that new data holds the promise of delivering new insights into biology, health, and diseaseFull story -
FDA Selects ArisGlobal Next-Generation Safety Platform to Implement New Integrated Safety Platform
Nov 27, 2018, 09:09 AM by Michael CroftMIAMI, FL, UNITED STATES - Nov 27, 2018 - The U.S. Food and Drug Administration (FDA) has selected Booz Allen Hamilton to support development, modernization, and enhancement of the FDA Adverse Event Reporting System (FAERS)Full story -
Check4Cancer launches innovative prostate cancer diagnosis pathway with AXA PPP healthcare
Nov 27, 2018, 05:06 AM by Michael CroftCAMBRIDGE, UK - Nov 27, 2018 - Prostate cancer is the most common cancer in men, with 1 in 8 diagnosed at some point in their livesFull story -
The Pistoia Alliance Announces Major Milestone in Unified Data Model Project to Promote Life Sciences Collaboration
Nov 27, 2018, 04:38 AM by Michael CroftBOSTON, MA - Nov 27, 2018 - The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life sciences R&D, today announced the latest release of its Unified Data Model (UDM) file format, v5Full story -
Everest Group Names HCL Technologies a Leader for Life Sciences Digital Services in North America
Nov 26, 2018, 12:52 PM by Michael CroftNOIDA, INDIA - Nov 26, 2018 - HCL Technologies (HCL), a leading global technology company, today announced that it has been recognized as a Leader in Everest Groups Life Sciences Digital Services North America PEAK MatrixFull story -
LGC acquires Seracare Life Sciences, strengthening its position in clinical quality control tools
Nov 26, 2018, 11:34 AM by Michael CroftTEDDINGTON, UNITED KINGDOM - Nov 26, 2018 - Today, LGC announced the acquisition of SeraCare Life Sciences, Inc., a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratoriesFull story -
Claim Of CRISPR'ed Baby Girls Stuns Genome Editing Summit
Nov 26, 2018, 08:14 AM by Michael CroftSTAT | A researcher's claim that he used genome editing to alter DNA of human embryos, resulting in the birth a few weeks ago of twin girls, stunned scientists.Full story -
Creative Biolabs Developed Anti-membrane Protein Antibody Using Phage Display Technology
Nov 24, 2018, 01:59 AM by Michael CroftSHIRLEY, NY - Nov 24, 2018 - Shirley, NY, Nov 24th, 2018, Creative Biolabs, as one of excellent suppliers and manufacturers in antibody production field, announced that the anti-membrane protein antibody1 has been developed successfully by using the phage display technology, which plays very crucial role in a majority of life science researchesFull story -
TARGET PharmaSolutions® to Advance Research in NASH and Hepatitis B Through New Collaboration with Gilead Sciences
Nov 21, 2018, 13:26 PM by Michael CroftCHAPEL HILL, NC, UNITED STATES - Nov 20, 2018 - TARGET PharmaSolutions, Inc., a company focused on real world evidence, is pleased to announce that it has entered into a strategic partnership with Gilead Sciences for TARGET-NASH and TARGET-HBVFull story -
Single-Cell Sequencing Is Opening Up New Avenues For Potential Treatments
Nov 21, 2018, 07:50 AM by Michael CroftSTAT | By quickly analyzing thousands - even millions - of cells, it's now possible to visualize the specific cellular culprits for any given disease.Full story